Friday, September 19, 2025
HomeIndustriesHealthcare

Healthcare

Biolase Announces Support for Project Home

BIOLASE, Inc., the global leader in dental lasers, announced that it has partnered with Project HOME, an organization that provides dental services to patients...

Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy

Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets, announced research suggesting lenalidomide, a molecular...

Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...

Transgene and BioInvent Announce Positive Progress for BT-001

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”), a biotech company focused on the discovery...

Novel Pre-clinical Results Regarding Oncosec’s Intratumoral Electroporation Platform

OncoSec Medical Incorporated, a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer,...
0FansLike
0FollowersFollow
spot_img

Hot Topics